Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:


Agricultural biotechnology (6)
Agriculture (13)
Biotechnology (8)
Business aspects (1)
Coordination and Cooperation (19)
Earth Sciences (6)
Economic Aspects (2)
Education and Training (7)
Electronics and Microelectronics (13)
Environmental Protection (6)
Evaluation (1)
Food (20)
Funding Programmes (1)
Healthcare delivery/services (96)
Information Processing and Information Systems (13)
Information and Media (15)
Information and communication technology applications (40)
Innovation and Technology Transfer (7)
Intellectual property rights (2)
Life Sciences (65)
Materials Technology (13)
Medical biotechnology (27)
Medicine and Health (193)
Meteorology (7)
Nanotechnology and Nanosciences (1)
Network technologies (7)
Other (2)
Policies (32)
Research ethics (2)
Robotics (12)
Scientific Research (120)
Social sciences and humanities (25)
Standards (7)
Veterinary and animal sciences (6)


Albania (2)
Argentina (2)
Australia (19)
Austria (93)
Bangladesh (1)
Belgium (199)
Benin (1)
Brazil (4)
Bulgaria (10)
Burkina Faso (1)
Cambodia (1)
Cameroon (2)
Canada (16)
China (2)
Colombia (2)
Congo (2)
Croatia (20)
Cuba (2)
Cyprus (14)
Czech Republic (35)
Côte d’Ivoire (1)
Denmark (129)
Ecuador (1)
Estonia (19)
Finland (92)
Former Yugoslav Republic of Macedonia (3)
France (276)
French Polynesia (1)
Gabon (2)
Germany (369)
Ghana (3)
Greece (94)
Hungary (33)
Iceland (18)
India (1)
Ireland (68)
Israel (68)
Italy (292)
Jamaica (1)
Japan (1)
Kosovo (2)
Kyrgyzstan (1)
Latvia (14)
Lithuania (2)
Luxembourg (22)
Malawi (2)
Malta (2)
Mexico (2)
Mozambique (4)
Nepal (2)
Netherlands (315)
New Caledonia (1)
Niger (2)
Norway (63)
Pakistan (2)
Poland (50)
Portugal (70)
Romania (22)
Senegal (6)
Serbia (12)
Slovakia (12)
Slovenia (32)
South Africa (7)
South Korea (6)
Spain (307)
Sri Lanka (1)
Sweden (164)
Switzerland (118)
Taiwan (4)
Tajikistan (1)
Tanzania (5)
The Gambia (2)
Turkey (15)
Uganda (7)
Ukraine (1)
United Kingdom (415)
United States (77)
Vietnam (1)
Zambia (3)

Content Type

Project (732)
News (85)
Event (44)
Result in Brief (18)
Report Summary (432)
Results Pack (6)
Programme (167)
Project Deliverable (312)
Project Publication (261)


Deutsch (22)
English (1947)
Español (22)
Français (22)
Italiano (22)
Polski (22)

Advanced search

Results 1 - 10 of 2057
12 3 4 5 6 7 8 9 10 > >| 
Revolutionary opto-biological methodology for aggressive HER2 cancer
ID: 783818
Start date: 2017-12-01, End date: 2020-11-30
According to World Health Organization, cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases per year. Breast cancer is the most common cancer among women, and is considered the second most common cancer overall...
Programme: H2020-EU.3.1.
Record Number: 213213
Last updated on: 2018-01-23
Non invasive Cell Based Liquid Biopsy Platform for Bladder Cancer
ID: 783654
Start date: 2017-12-01, End date: 2020-11-30
OneRNA4Bladder aims to save lives and reduce cost of care for bladder cancer treatment – the most expensive type of cancer to treat due to expensive diagnostic procedures and ineffective drugs leading to a recurrence rate of 70%. Implementing the OneRNA4Bladder system for...
Programme: H2020-EU.3.1.
Record Number: 213205
Last updated on: 2018-01-23
Manufacturing and testing of an allogeneic gamma delta T cell therapy for the treatment of cancer
ID: 783506
Start date: 2017-10-01, End date: 2019-09-30
Europe is experiencing an unprecedented cancer epidemic, driven by our ageing population. Traditional cancer treatments such as surgery, chemotherapy and radiation therapy have demonstrated very limited efficacy for patients with late-stage disease and often cause considerable...
Programme: H2020-EU.3.1.
Record Number: 213204
Last updated on: 2018-01-23
Soraprazan - a new regenerative therapy for Stargardt's disease
ID: 779317
Start date: 2017-12-01, End date: 2021-11-30
Soraprazan – a new regenerative therapy for Stargardt’s diseaseAbnormal accumulation of lipofuscin in the RPE cells is a hallmark in Stargardt's disease. As lipofuscin cannot be removed from the RPE cells in the eyes neither spontaneously nor with existing therapies, the...
Programme: H2020-EU.3.1.3.
Record Number: 213048
Last updated on: 2018-01-23
Liquid biopsies and Imaging for improved cancer care
ID: 755333
Start date: 2018-01-01, End date: 2021-12-31
LIMA’s overall objective is to develop and validate technologies and tools to include liquid biopsies in the clinical workflow, aiming at introducing a more precise and dynamic genetic characterization of tumor at the diagnosis and during treatment phases. This will be done...
Programme: H2020-EU.3.1.1.
Record Number: 212693
Last updated on: 2018-01-23
Randomized, Comparison Of Risk-Stratified versus Standard Breast Cancer Screening In European Women Aged 40-74
ID: 755394
Start date: 2018-01-01, End date: 2025-12-31
MyPeBS addresses the crucial and timely question of the future of breast cancer screening in Europe. Indeed current standard mammographic screening, with entry stratified by age alone, has recently been largely questioned. Despite a demonstrated mean 20% reduction in breast...
Programme: H2020-EU.3.1.3.
Record Number: 212694
Last updated on: 2018-01-23
A multidisciplinary approach for the stratification of patients with carotid artery disease
ID: 755320
Start date: 2018-01-01, End date: 2022-12-31
Carotid artery disease, the primary trigger of ischaemic cerebrovascular events including stroke, causes major morbidity, mortality and healthcare costs worldwide. Still, treatment is based on criteria established in the 90s that do not take into account the molecular...
Programme: H2020-EU.3.1.1.
Record Number: 212692
Last updated on: 2018-01-23
A pivotal phase IIb clinical trial of inhaled alginate oligosaccharide (OligoG) for cystic fibrosis
ID: 755234
Start date: 2018-01-01, End date: 2020-12-31
The objective of the current proposal is to advance the orphan drug OligoG CF-5/20 (OligoG) through a pivotal phase IIb clinical trial, to enable a new and improved therapeutic approach for the orphan disease cystic fibrosis by 2020.The study drug is an alginate...
Programme: H2020-EU.3.1.3.
Record Number: 212691
Last updated on: 2018-01-23
Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome
ID: 755225
Start date: 2018-01-01, End date: 2022-12-31
Crigler-Najjar syndrome (CN) is a rare recessive disorder caused by mutations in the uridine diphosphate glucuronosyltransferase 1A1(UGT1A1) gene. CN is a life-threatening disease with no cure which constitutes a severe burden for the patients, their families, and the society...
Programme: H2020-EU.3.1.3.
Record Number: 212689
Last updated on: 2018-01-23
A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma.
ID: 755179
Start date: 2017-12-01, End date: 2020-11-30
"Glioma is a rare brain cancer with one of the highest mortality rates. It is considered an orphan disease due to its low prevalence (less than 0.5 cases per 10,000 inhabitants in the EU) and the lack of plausible therapies. Based on the discovery of the lipid proliferation...
Programme: H2020-EU.3.1.3.
Record Number: 212688
Last updated on: 2018-01-23
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2018-01-24
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top